PARP14 is an interferon (IFN)-induced host factor that promotes IFN production and affects the replication of multiple viruses.

Saved in:
Bibliographic Details
Title: PARP14 is an interferon (IFN)-induced host factor that promotes IFN production and affects the replication of multiple viruses.
Authors: Parthasarathy S; Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045, USA., Saenjamsai P; Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045, USA., Hao H; Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045, USA., Ferkul A; Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045, USA., Pfannenstiel JJ; Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045, USA., Bejan DS; Department of Chemical Physiology and Biochemistry, Oregon Health Sciences University, Portland, OR, 97239, USA., Chen Y; Department of Molecular Biosciences, University of Texas, Austin, TX, 78712, USA., Suder EL; Department of Microbiology, Boston University School of Medicine, Boston, MA, 02118, USA.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, 02118, USA.; Center for Emerging Infectious Diseases Policy & Research, Boston University, Boston, MA, 02118, USA., Schwarting N; Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045, USA., Aikawa M; Center for Excellence in Vascular Biology (P.K.J., M.A., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.; Center for Interdisciplinary Cardiovascular Sciences (M.A., E.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.; Channing Division of Network Medicine (M.A.), Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA., Muhlberger E; Department of Microbiology, Boston University School of Medicine, Boston, MA, 02118, USA.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, 02118, USA.; Center for Emerging Infectious Diseases Policy & Research, Boston University, Boston, MA, 02118, USA., Hume AJ; Department of Microbiology, Boston University School of Medicine, Boston, MA, 02118, USA.; National Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, 02118, USA.; Center for Emerging Infectious Diseases Policy & Research, Boston University, Boston, MA, 02118, USA., Orozco RC; Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045, USA., Sullivan CS; Department of Molecular Biosciences, University of Texas, Austin, TX, 78712, USA., Cohen MS; Department of Chemical Physiology and Biochemistry, Oregon Health Sciences University, Portland, OR, 97239, USA., Davido DJ; Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045, USA., Fehr AR; Department of Molecular Biosciences, University of Kansas, Lawrence, Kansas 66045, USA.
Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 Apr 16. Date of Electronic Publication: 2025 Apr 16.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.1101/2024.04.26.591186